Short-term naratriptan treatment does not worsen pain sensitivity in migraine: a prospective clinical trial
Background Migraine represents one of the most disabling neurological disorders, frequently underdiagnosed and undertreated, with predominant reliance on acute medications that may precipitate medication overuse headache. Evidence indicates that triptans, including naratriptan, modulate central sensitization—a key path...